Surrounded by her toys and holding up her insulin pen, Siwar sits on the floor of her family's makeshift home in Arsal, north Lebanon. After her family fled the war in Syria and took refuge in Lebanon, Siwar was diagnosed with type 1 diabetes and began her treatment at the MSF clinic in town. Photo credit: Carmen Yahchouchi/MSF
Letter |

Open letter to Sanofi on barriers to accessing diabetes medicines

Report Cover Image
Photo credit: Carmen Yahchouchi/MSF

MSF sent this open letter to the CEO of pharmaceutical corporation Sanofi to urge action for greater access to insulin for people living with diabetes in humanitarian and resource-poor settings.

UPDATE, 11 November 2024: Sanofi responded on 10 October 2024 with this reply letter, which we have marked up with our comments.